Modulation of interleukin-6 and matrix metalloproteinase 2 expression in human fibroblast-like synoviocytes by functional ionotropic glutamate receptors

Arthritis and Rheumatism

Volumn 56, Issue 8, 2007, Pages 2523-2534

  Flood, Sophie ^a   Parri, Rheinallt ^b   Williams, Anwen ^a   Duance, Victor ^a   Mason, Deborah ^a,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CALCIUM; CYTOKINE; GELATIN; GELATINASE A; GELATINASE B; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 4; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; INTERLEUKIN 6; IONOTROPIC RECEPTOR; KAINIC ACID; KAINIC ACID RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; RECEPTOR SUBUNIT; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST LIKE SYNOVIOCYTE; FLUORESCENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; JOINT DESTRUCTION; KNEE MENISCUS; NONHUMAN; PATELLA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIOCYTE; ZYMOGRAPHY;

ADULT; ANIMALS; CALCIUM; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; FIBROBLASTS; GENE EXPRESSION; GLUTAMIC ACID; HINDLIMB; HUMANS; INTERLEUKIN-6; KAINIC ACID; MALE; MATRIX METALLOPROTEINASE 2; MENISCI, TIBIAL; MIDDLE AGED; N-METHYLASPARTATE; RATS; RECEPTORS, KAINIC ACID; RECEPTORS, METABOTROPIC GLUTAMATE; RNA, MESSENGER; SYNOVIAL MEMBRANE; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 34547794078     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22829     Document Type: Article

References (39)

1. Desgeorges A, Gabay C, Silacci P, Novick D, Roux-Lombard P, Grau G, et al. Concentrations and origins of soluble interleukin 6 rcceptor-α in serum and synovial fluid. J Rheumatol 1997;24: 1510-6.
2. Vervoordeldonk MJ, Tak PP. Cytokines in rheumatoid arthritis. Curr Rheumatol Rep 2002;4:208-17.
3. Wong PK, Campbell IK, Egan PJ, Ernst M, Wicks IP. The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum 2003;48:1177-89.
4. Boe A, Baiocchi M, Carbonatto M, Papoian R, Serlupi-Crescenzi O. Interleukin 6 knock-out mice arc resistant to antigen-induced experimental arthritis. Cytokine 1999;11:1057-64.
5. McNearney T, Speegle D, Lawand N, Lisse J, Westlund KN. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 2000;27:739-45.
6. Lawand NB, McNearney T, Westlund KN. Amino acid release into the knee joint: key role in nociception and inflammation. Pain 2000;86:69-74.
7. McNearney T, Baethge BA, Cao S, Alam R, Lisse JR, Westlund KN. Excitatory amino acids, TNF-α, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol 2004;137:621-7.
8. Hinoi E, Wang L, Takemori A, Yoneda Y. Functional expression of particular isoforms of excitatory amino acid transporters by rodent cartilage. Biochem Pharmacol 2005;70:70-81.
9. Salter DM, Wright MO, Millward-Sadler SJ. NMDA receptor expression and roles in human articular chondrocyte mechanotransduction. Biorheology 2004;41:273-81.
10. Mason DJ. Glutamate signalling and its potential application to tissue engineering of bone. Eur Cell Mater 2004;7:12-25.
11. Genever PG, Maxfield SJ, Kennovin GD, Maltman J, Bowgen CJ, Raxworthy MJ, et al. Evidence for a novel glutamate-mediated signaling pathway in keratinocytes. J Invest Dermatol 1999;112: 337-42.
12. Cooper B, Chebib M, Shen J, King NJ, Darvey IG, Kuchel PW, et al. Structural selectivity and molecular nature of L-glutamate transport in cultured human fibroblasts. Arch Biochem Biophys 1998;353:356-64.
13. Hinoi E, Ohashi R, Miyata S, Kato Y, Iemata M, Hojo H, et al. Excitatory amino acid transporters expressed by synovial fibroblasts in rats with collagen-induced arthritis. Biochem Pharmacol 2005;70:1744-55.
14. Gu Y, Genever PG, Skerry TM, Publicover SJ. The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors. Calcif Tissue Int 2002;70:194-203.
15. Gu Y, Publicover SJ. Expression of functional metabotropic glutamate receptors in primary cultured rat osteoblasts: cross-talk with N-methyl-D-aspartate receptors. J Biol Chem 2000;275: 34252-9.
16. Laketic-Ljubojevic I, Suva LJ, Maathuis FJ, Sanders D, Skerry TM. Functional characterization of N-methyl-D-aspartic acid-gated channels in bone cells. Bone 1999;25:631-7.
17. Sokolov BP. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics J Neurochem 1998;71:2454-64.
18. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M. Synovium as a source of interleukin 6 in vitro: contribution to local and systemic manifestations of arthritis. J Clin Invest 1989;83: 585-92.
19. Parada-Turska J, Rzeski W, Majdan M, Kandefer-Szerszen M, Turski WA. Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro. Eur J Pharmacol 2006;535:95-7.
20. Blain EJ, Gilbert SJ, Wardale RJ, Capper SJ, Mason DJ, Duance VC. Up-regulation of matrix metalloproteinase expression and activation following cyclical compressive loading of articular cartilage in vitro. Arch Biochem Biophys 2001;396:49-55.
21. 2+ oscillations. Neuroscience 2003;120: 979-92.
22. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 2006;45:669-75.
23. Jean YH, Wen ZH, Chang YC, Huang GS, Lee HS, Hsieh SP, et al. Increased concentrations of neuro-excitatory amino acids in rat anterior cruciate ligament-transected knee joint dialysates: a microdialysis study. J Orthop Res 2005;23:569-75.
24. Dudhia J, McAlindon A, Muir P, Bayliss M. The meniscus - structure, composition, and pathology. In: Hazleman B, Riley G, Speed C, editors. Soft tissue rheumatology. Oxford: Oxford Press; 2004. p. 80-96.
25. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000;59:455-61.
26. Smolian H, Aurer A, Sittinger M, Zacher J, Bernimoulin JP, Burmester GR, et al. Secretion of gelatinases and activation of gclatinase A (MMP-2) by human rheumatoid synovial fibroblasts. Biol Chem 2001;382:1491-9.
27. Szklarczyk A, Lapinska J, Rylski M, McKay RD, Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 2002;22:920-30.
28. Jourquin J, Tremblay E, Decanis N, Charton G, Hanessian S, Chollet AM, et al. Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci 2003;18:1507-17.
29. Somerville RP, Oblander SA, Apte SS. Matrix metalloproteinases: old dogs with new tricks. Genome Biol 2003;4:216.1-216.11.
30. Ito A, Mukaiyama A, Itoh Y, Nagase H, Thogersen IB, Enghild JJ, et al. Degradation of interleukin 1β by matrix metalloproteinases. J Biol Chem 1996;271:14657-60.
31. Itoh T, Matsuda H, Tanioka M, Kuwabara K, Itohara S, Suzuki R. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol 2002;169:2643-7.
32. Nowell MA, Richards PJ, Horiuchi S, Yamamoto N, Rose-John S, Topley N, et al. Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J Immunol 2003;171:3202-9.
33. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 2001;15:43-58.
34. Jones SA, Rose-John S. The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Biochim Biophys Acta 2002;1592:251-63.
35. Flannery CR, Little CB, Hughes CE, Curtis CL, Caterson B, Jones SA. IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage. Matrix Biol 2000; 19:549-53.
36. Gleason EL, Spitzer NC. AMPA and NMDA receptors expressed by differentiating Xenopus spinal neurons. J Neurophysiol 1998; 79:2986-98.
37. Brorson JR, Bleakman D, Gibbons SJ, Miller RJ. The properties of intracellular calcium stores in cultured rat cerebellar neurons. J Neurosci 1991;11:4024-43.
38. 2+ imaging reveals neurotransmitter receptors for glutamate in taste receptor cells. J Neurosci 2000;20:7978-85.
39. Parada-Turska J, Rzeski W, Zgrajka W, Majdan M, Kandefer-Szerszen M, Turski W. Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro. Rheumatol Int 2006;26:422-6.